| Autor: |
Goumas G; Department of Public Health Policy, School of Public Health, University of West Attica, 115 21 Athens, Greece., Dardavesis TI; Laboratory of Hygiene, Social & Preventive Medicine and Medical Statistics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece., Syrigos K; Oncology Unit, 3rd Department of Medicine, 'Sotiria' Hospital for Diseases of the Chest, National and Kapodistrian University of Athens, 115 27 Athens, Greece., Syrigos N; Oncology Unit, 3rd Department of Medicine, 'Sotiria' Hospital for Diseases of the Chest, National and Kapodistrian University of Athens, 115 27 Athens, Greece.; Dana-Farber Cancer Institute, Boston, MA 02215, USA., Simou E; Department of Public Health Policy, School of Public Health, University of West Attica, 115 21 Athens, Greece. |
| Abstrakt: |
The emergence of digitalization and artificial intelligence has had a profound impact on society, especially in the field of medicine. Digital health is now a reality, with an increasing number of people using chatbots for prognostic or diagnostic purposes, therapeutic planning, and monitoring, as well as for nutritional and mental health support. Initially designed for various purposes, chatbots have demonstrated significant advantages in the medical field, as indicated by multiple sources. However, there are conflicting views in the current literature, with some sources highlighting their drawbacks and limitations, particularly in their use in oncology. This state-of-the-art review article seeks to present both the benefits and the drawbacks of chatbots in the context of medicine and cancer, while also addressing the challenges in their implementation, offering expert insights on the subject. |
